CLINICAL TRIALS PROFILE FOR GRALISE
✉ Email this page to a colleague
All Clinical Trials for GRALISE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01067144 ↗ | Stanford Accelerated Recovery Trial (START) | Terminated | Stanford University | Phase 3 | 2010-05-01 | The goal of this study is to determine whether administering Gabapentin prior to surgery affects duration of pain and opioid use post-surgery. The investigators aim to compare gabapentin to placebo in a prospective, randomized clinical trial in which patients will be followed post-surgery until pain resolves and opioid use ceases. |
| NCT01301001 ↗ | A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response | Completed | University of Tennessee Health Science Center | N/A | 2012-08-01 | The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options. |
| NCT01301001 ↗ | A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response | Completed | University of Tennessee | N/A | 2012-08-01 | The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options. |
| NCT01533753 ↗ | Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer | Terminated | University of Wisconsin, Madison | Phase 2 | 2012-02-01 | The purpose of this study is to assess the change in quality of life over a 6 month period between gabapentin and venlafaxine in men with prostate cancer treated for hot flashes related to androgen deprivation therapy. |
| NCT01623271 ↗ | Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise) | Terminated | Massachusetts General Hospital | N/A | 2013-05-01 | The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with certain types of neuropathic pain without causing too many side effects. |
| NCT01675960 ↗ | Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children | Terminated | Gillette Children's Specialty Healthcare | Phase 2 | 2012-04-01 | This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources. |
| NCT01675960 ↗ | Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children | Terminated | Scott Schwantes, M.D. | Phase 2 | 2012-04-01 | This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GRALISE
Condition Name
Clinical Trial Locations for GRALISE
Trials by Country
Clinical Trial Progress for GRALISE
Clinical Trial Phase
Clinical Trial Sponsors for GRALISE
Sponsor Name
